Active disease modification and tissue regeneration across the high-prevalence chronic conditions that most affect cats and dogs.
What each condition is, how stem-cell therapy addresses it, and the outcomes we've seen.
OA is one of the most common — and painful — chronic conditions in dogs. Mesenchymal stem cells calm joint inflammation and support cartilage repair, reducing pain at the source rather than just masking it. In a peer-reviewed pilot study, dogs with hip OA showed an 85% reduction in pain and lameness.
CKD is a leading cause of decline in older cats. MSCs' immune-modulating and anti-inflammatory properties help protect kidney tissue and support function — aiming to slow progression and improve quality of life for chronic patients.
FCGS is a debilitating, painful chronic oral inflammation in cats that often resists conventional treatment. CuraCell's therapy has shown around 70% resolution of chronic oral inflammation — restoring comfort and appetite.
For stubborn atopic dermatitis, MSCs offer long-term management of chronic skin inflammation. In spinal and nerve injuries, CuraCell has helped restore mobility even in poor-prognosis cases — giving pets a real chance at recovery.
Talk to a CuraCell clinic about whether stem-cell therapy is right for your cat or dog.